Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.
Channel 13's Taylor Rocha speaks to the general manager of the Desert Dogs and his late son's legacy through the Tucker Out Lymphoma Night. HENDERSON (KTNV) — Saturday night, the Las Vegas ...